CAS 4630-95-9

Prifinium bromide

Description:

Prifinium bromide is a quaternary ammonium compound that functions primarily as an anticholinergic agent. It is characterized by its ability to block the action of acetylcholine at muscarinic receptors, which makes it useful in various medical applications, particularly in the treatment of gastrointestinal disorders and as a pre-anesthetic medication to reduce salivation and secretions. The compound typically appears as a white to off-white crystalline solid and is soluble in water and organic solvents. Its chemical structure includes a central nitrogen atom bonded to four alkyl groups, contributing to its quaternary nature. Prifinium bromide is known for its relatively low toxicity, but like other anticholinergics, it can cause side effects such as dry mouth, blurred vision, and urinary retention. Proper handling and dosage are essential to minimize adverse effects. As with any pharmaceutical compound, its use should be guided by medical professionals, considering individual patient needs and potential interactions with other medications.

Formula: C₂₂H₂₈N·Br

InChI: InChI=1S/C22H28N.BrH/c1-4-23(5-2)17-16-21(18(23)3)22(19-12-8-6-9-13-19)20-14-10-7-11-15-20;/h6-15,18H,4-5,16-17H2,1-3H3;1H/q+1;/p-1

InChI key: InChIKey=UCGJZJXOPSNTGZ-UHFFFAOYSA-M

SMILES: C(=C1C(C)[N+](CC)(CC)CC1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-]

Synonyms:

• 1,1-Diethyl-2-methyl-3-diphenylmethylenepyrrolidinium bromide
• 3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidinium bromide
• 3-(Diphenylmethylene)-1-ethyl-2-methylpyrrolidine ethyl bromide
• 3-(Diphenylmethylidene)-1,1-Diethyl-2-Methylpyrrolidinium Bromide
• Bromure de prifinium
• Bromure de prifinium [INN-French]
• Bromuro de prifinio
• Bromuro de prifinio [INN-Spanish]
• Padrin
• Prifinii bromidum
• Prifinii bromidum [INN-Latin]
• Prifinio bromuro
• Prifinio bromuro [DCIT]
• Prifinium bromide [INN:JAN]
• Pyrodifenium bromide
• Pyrrolidinium, 1,1-diethyl-3-diphenylmethylene-2-methyl-, bromide
• Pyrrolidinium, 3-(diphenylmethylene)-1,1-diethyl-2-methyl-, bromide
• Pyrrolidinium, 3-(diphenylmethylene)-1,1-diethyl-2-methyl-, bromide (1:1)
• Riabal
• Unii-3B7O9Zc520

3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidin-1-ium bromide

CAS: 4630-95-9

Formula: C₂₂H₂₈BrN

Purity: 97%

Color and Shape: Solid

Molecular weight: 386.3684

Ref: IN-DA003TYG

prifinium bromide

CAS: 4630-95-9

prifinium bromide

Purity: ≥95%

Molecular weight: 386.37g/mol

Ref: 54-BUP11916

Prifinium Bromide

CAS: 4630-95-9

Formula: C₂₂H₂₈N·Br

Color and Shape: White To Off-White Solid

Molecular weight: 306.47 79.90

Ref: 4Z-P-280001

3-(Diphenylmethylene)-1,1-Diethyl-2-Methylpyrrolidin-1-Ium Bromide

CAS: 4630-95-9

3-(Diphenylmethylene)-1,1-Diethyl-2-Methylpyrrolidin-1-Ium Bromide

Purity: 99%

Molecular weight: 386.37g/mol

Ref: 54-OR1010700

Prifinium bromide

CAS: 4630-95-9

Prifinium bromide is a quaternary ammon antimuscarinic. It inhibits hyperkinesia of the digestive organs and urinary tract and has a spasmolytic action.

Formula: C₂₂H₂₈BrN

Purity: 97.99%

Color and Shape: Solid

Molecular weight: 386.37

Ref: TM-T9420

3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidin-1-ium bromide

CAS: 4630-95-9

Formula: C₂₂H₂₈BrN

Purity: 97%

Molecular weight: 386.377

Ref: 10-F449919

Prifinium Bromide

Controlled Product

CAS: 4630-95-9

Stability Light Sensitive
Applications Prifinium Bromide is a synthetic antispasmodic drug; parasympatholytic. Prifinium Bromide is used as a quartenary anticholinergic agent.
References Kumada, S. et al.: Arzneim.-Forsch., 20, 237 (1970); Nakai, T. et al.: Arzneim.-Forsch., 20, 1112 (1970); Bettini, V. et al.: Farm. Ed. Prat., 33, 392 (1978);

Formula: C₂₂H₂₈N·Br

Color and Shape: Neat

Molecular weight: 386.37

Ref: TR-P717500

Prifiniumbromide

CAS: 4630-95-9

Prifiniumbromide is an analog of GABA, which is a neurotransmitter found in the brain. It has been shown to be effective in patients with diabetic neuropathy and geriatric patients with constipation. Prifiniumbromide has also been used to treat inflammatory bowel disease and bladder disorders, such as detrusor muscle dysfunction. In addition, it has been shown to increase urinary output in patients with metabolic disorders.

Formula: C₂₂H₂₈BrN

Purity: Min. 95%

Molecular weight: 386.37 g/mol

Ref: 3D-FP152019